Viral kinetics analysis and virological characterization of treatment failures in patients with chronic hepatitis C treated with sofosbuvir and an NS5A inhibitor
Slim FOURATI,
J Guedj,
Stephane CHEVALIEZ,
THT Nguyen,
F Roudot-Thoraval,
Isaac RUIZ,
Alexandre SOULIER,
G Scoazec,
A Varaut,
Lila POITEAU,
Murielle FRANCOIS,
A Mallat,
Christophe HEZODE,
Jean-Michel PAWLOTSKY,
Aliment Pharmacol Ther. 01/03/2018;47(5) : 665-673 10.1111/apt.14478. 22/12/2017
Clinical utility of HCV core antigen detection and quantification using serum samples and dried blood spots in people who inject drugs in Dar-es-Salaam, Tanzania
Z Mohamed,
J Mbwambo,
Y Shimakawa,
Lila POITEAU,
Stephane CHEVALIEZ,
Jean-Michel PAWLOTSKY,
J Rwegasha,
S Bhagani,
SD Taylor-Robinson,
J Makani,
MR Thursz,
M Lemoine,
j Int AIDS Soc. 19/09/2017;20(1) : 21856 10.7448/IAS.20.1.21856.
HCV core antigen as an alternate test to HCV RNA for assessment of virologic responses to all-oral, interferon-free treatment in HCV genotype 1 infected patients.
JK Rockstroh,
JJ Feld,
Stephane CHEVALIEZ,
K Cheng,
H Wedemeyer,
C Sarrazin,
B Maasoumy,
C Herman,
J Hackett,
DE Cohen,
GJ Dawson,
G Cloherty,
Jean-Michel PAWLOTSKY,
J Virol Methods. 01/07/2017;245 : 14-18 10.1016/j.jviromet.2017.03.002. 27/03/2017
Sofosbuvir-Daclatasvir-Simeprevir Plus Ribavirin in Direct-Acting Antiviral-Experienced Patients With Hepatitis C.
Christophe HEZODE,
Slim FOURATI,
Stephane CHEVALIEZ,
G Scoazec,
Alexandre SOULIER,
A Varaut,
M Francois,
Isaac RUIZ,
F Roudot-Thoraval,
A Mallat,
Jean-Michel PAWLOTSKY,
Clin Infect Dis. 01/06/2017;64(11) : 1615-1618 10.1093/cid/cix214. 24/07/2017
HCV Ag quantification as a one-step procedure in diagnosing chronic hepatitis C infection in Cameroon: the ANRS 12336 study.
L Duchesne,
R Njouom,
F Lissock,
GF Tamko-Mella,
Sandrine RALLIER,
Lila POITEAU,
Alexandre SOULIER,
Stephane CHEVALIEZ,
G Vernet,
N Rouveau,
Jean-Michel PAWLOTSKY,
PM Girard,
K Lacombe,
J Int AIDS Soc. 15/05/2017;20(1) : 1-8 10.7448/IAS.20.1.21446.
